The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 09, 2010

Filed:

Nov. 10, 2005
Applicants:

Ryo Mizojiri, Takatsuki, JP;

Takahiro Oka, Takatsuki, JP;

Kenta Aoki, Takatsuki, JP;

Satoru Noji, Takatsuki, JP;

Yoko Matsumoto, Takatsuki, JP;

Toshihiro Sato, Takatsuki, JP;

Izuru Ando, Takatsuki, JP;

Yasushi Niwa, Takatsuki, JP;

Inventors:

Ryo Mizojiri, Takatsuki, JP;

Takahiro Oka, Takatsuki, JP;

Kenta Aoki, Takatsuki, JP;

Satoru Noji, Takatsuki, JP;

Yoko Matsumoto, Takatsuki, JP;

Toshihiro Sato, Takatsuki, JP;

Izuru Ando, Takatsuki, JP;

Yasushi Niwa, Takatsuki, JP;

Assignee:

Japan Tobacco Inc., Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 1/16 (2006.01); A61P 31/12 (2006.01); A61P 43/00 (2006.01); A61K 31/553 (2006.01); A61K 31/5517 (2006.01); C07D 498/12 (2006.01); C07D 267/02 (2006.01); C07D 495/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a thienopyrrole compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable a salt thereof, and a hepatitis C virus (HCV) polymerase inhibitor and a therapeutic agent for hepatitis C containing this compound as an active ingredient. The compound of the present invention shows an anti-HCV activity based on the HCV polymerase inhibitory activity, and useful as an agent for the prophylaxis or treatment of hepatitis C.


Find Patent Forward Citations

Loading…